Consolidated statement of changes in equity For the year ended 31 December 2017 Equity attributable Share to equity NonShare premium Own Other Translation Retained holders of controlling Total capital account shares reserves reserves earnings the parent interests equity m m m m m m m m m 1 January 2016 33.1 177.1 9.3 134.1 5.8 220.0 549.2 0.4 549.6 Net profit for the year 67.0 67.0 67.0 Exchange differences on translation of overseas operations 65.5 65.5 65.5 Cumulative exchange differences recycled to profit or loss on disposal of businesses 2.2 2.2 2.2 Actuarial losses on defined benefit pension schemes net of deferred tax 4.0 4.0 4.0 Total comprehensive income for the year 63.3 63.0 126.3 126.3 Acquired in the year settlement of share options 1.3 0.7 0.6 Share-based payments 0.5 0.5 0.5 Dividends paid 48.1 48.1 48.1 31 December 2016 33.1 177.1 8.0 133.9 57.5 234.3 627.9 0.4 628.3 Net profit for the year 97.1 97.1 0.2 97.3 Exchange differences on translation of overseas operations 11.6 11.6 0.1 11.7 Actuarial gains on defined benefit pension schemes net of deferred tax 5.7 5.7 5.7 Total comprehensive income for the year 11.6 102.8 91.2 0.1 91.3 Acquired in the year settlement of share options 0.8 0.7 0.1 0.1 Share-based payments 7.8 7.8 7.8 Deferred tax on share-based payment transactions 0.6 0.6 0.6 Dividends paid 30.6 30.6 30.6 31 December 2017 33.1 177.1 7.2 141.0 45.9 307.1 697.0 0.5 697.5 Included in other reserves is the capital redemption reserve of 129.8m 2016: 129.8m and the share-based payments reserve of 10.4m 2016: 3.3m.
The own shares reserve represents the cost of shares in Bodycote plc purchased in the market.
At 31 December 2017 1,171,190 2016: 1,289,378 ordinary shares of 17 3 11p each were held by the Bodycote International Employee Benefit Trust to satisfy share-based payments under the Groups incentive schemes see note 26.
88 Bodycote plc annual report for the year ended 31 December 2017 25695 19 March 2018 3:24 PM Proof 7
